Verrucous Melanoma Presenting as a Cutaneous Horn.
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
01 Sep 2022
01 Sep 2022
Historique:
pubmed:
2
6
2022
medline:
20
8
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
Verrucous malignant melanoma (MM) is a rare variant of melanoma that often presents diagnostic challenges. This case highlights the unique presentation of verrucous MM underlying a cutaneous horn. It is vital for dermatologists to be aware of this potentially benign-appearing variant to be able to diagnose and treat MM early on.
Identifiants
pubmed: 35642969
doi: 10.1097/DAD.0000000000002222
pii: 00000372-202209000-00023
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e106-e107Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Cristóbal MC, Urbina F, Espinoza A. Cutaneous horn malignant melanoma. Dermatol Surg. 2007;33:997–999.
Nishida H, Daa T, Kashima K, et al. Cutaneous horn malignant melanoma. Dermatol Rep. 2013;5:e3.
Türel Ermertcan A, Eskiizmir G, GençgLan G, et al. Lentigo malignant melanoma presenting with cutaneous horn. Dermatol Surg. 2010;36:1759–1762.
Steiner A, Konrad K, Pehamberger H, et al. Verrucous malignant melanoma. Arch Dermatol. 1988;124:1534–1537.
Damianov N, Tronnier M, Koleva N, et al. Verrucous-keratotic malignant melanoma (VKMM). Open Access Maced J Med Sci. 2017;5:547–548.
Cabrera R, Recule F. Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings. Am J Clin Dermatol. 2018;19(suppl 1):15–23.
Tran PT, Truong AK, Munday W, et al. Verrucous melanoma masquerading as a seborrheic keratosis. Dermatol Online J. 2019;25:13030/qt1m07k7fm.
Yang K, Mahalingam M. Differing biologic behaviors of desmoplastic melanoma subtypes: insights based on histopathologic, immunohistochemical, and genetic analyses. J Am Acad Dermatol. 2020;83:523–531.
Kiyohara T, Nagano N, Miyamoto M, et al. BRAF-mutated, acral verrucous melanoma successfully treated by dabrafenib plus trametinib combination therapy. Clin Exp Dermatol. 2019;44:945–946.
Rabbie R, Ferguson P, Molina-Aguilar C, et al. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019;247:539–551.